Patent · US Active

Sphingosine kinase type 1 inhibitors and uses thereof

US10456370B2 · kind B2 · utility

3Cited by

7References

9Claims

0Family size

Assignees

ENZO THERAPEUTICS, INC. · US
Virginia Commonwealth University · US

Inventors

Sarah Spiegel · Richmond, US
Robert Elliot Zipkin · Wynnebrook Manor, US
Jeffrey Kroll Adams · Fort Washington, US

Key dates

Filing date	Nov 26, 2018
Grant date	Oct 29, 2019
Priority date	—
Expiry date	Nov 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/092
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are inhibitors of sphingosine kinase Type I and their use in the treatment of asthma, among other indications and diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.